Entecavir Tablets, USP, 1 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.
Published October 8, 2025 · Recall initiated: September 24, 2025
Summary
FDA records drug Class II recall D-0002-2026, published October 8, 2025 and initiated September 24, 2025. Recalling firm: Zydus Pharmaceuticals (USA) Inc; Status: Ongoing; Reported quantity: 600 30-count bottles; Lot: Lot#: E409309, Exp 12/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity
What to do
Voluntary: Firm initiated · Letter
Get an email if ENTECAVIR has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ENTECAVIR
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc
- Distributor
- Distributed Nationwide in the USA
- Lot
- Lot#: E409309, Exp 12/31/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEntecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad,October 8, 2025
- FDACarbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x10 unit dose cards), Rx Only,October 8, 2025
- FDAVasoview Hemopro 3 Endoscopic Vessel Harvesting System Model No. C-VH-6000. The VASOVIEW HEMOPRO 3 EndoscopicOctober 1, 2025
- FDAEntecavir Tablets, USP, 1 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India,September 24, 2025
- FDAEntecavir Tablets, USP, 0.5 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad,September 24, 2025
- FDAEntecavir Tablets 0.5 mg, 30 tablets per container, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc.,August 23, 2017
Questions about this recall
Was Entecavir Tablets, USP, 1 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06. recalled?
Yes. FDA published recall D-0002-2026 on October 8, 2025. Reported hazard: Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ENTECAVIR.